Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
Introduction. The risk of gastrointestinal (GI) bleeding with rivaroxaban has not been studied extensively. The aim of our study was to assess this risk in comparison to warfarin. Methods. We examined the medical records for patients who were started on rivaroxaban or warfarin from April 2011 to Apr...
Saved in:
Main Authors: | Muhammed Sherid, Samian Sulaiman, Salih Samo, Husein Husein, Ruth Tupper, Charles Spurr, Humberto Sifuentes, Subbaramiah Sridhar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/9589036 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Klippel-Trenaunay Syndrome Causing Life-Threatening GI Bleeding: A Case Report and Review of the Literature
by: Salih Samo, et al.
Published: (2013-01-01) -
Metastatic Infiltrating Ductal Carcinoma of the Breast to the Colon: A Case Report and Literature Review
by: Salih Samo, et al.
Published: (2013-01-01) -
Intestinal Tuberculosis Presenting with Gastrointestinal Bleeding in Patient on Warfarin Therapy
by: Werimo Pascal Kuka, et al.
Published: (2022-01-01) -
Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
by: Abel Tenaw Tasamma, et al.
Published: (2025-01-01) -
Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
by: Evren Uygungül, et al.
Published: (2014-01-01)